Press release
Latest Research Analysis on Cardiovascular Drugs Market Will Rise At 1.5%CAGR BY 2025
MRRSE
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global cardiovascular drugs market across regions.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year and 2015 as historic year. Market size estimations involved in-depth study of product features of different drug class and various pipeline products. Additionally, market related factors such as preference for self-medication, regional availability of specialty drugs, patent expiration of cardiovascular drugs & availability of generic drugs, projected launch of new drugs etc. in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Browse Full Report With TOC Click here @ https://www.mrrse.com/cardiovascular-drugs-market
Cardiovascular Drugs Market: Segmentation
Cardiovascular diseases are estimated to affect population across the globe. Cardiovascular diseases comprise diseases and disorders related to heart and blood vessels. Various drugs are available and are under development for treating cardiovascular diseases based on various indications, such as arrhythmia, myocardial infarction, atherosclerosis, etc.
Based on drug class, the global cardiovascular drugs market has been segmented into anti hyperlipidemics, anti-hypertensives, anti-coagulants, anti-fibrinolytics, anti-arrhythmic, and others. The others segment of drug class include drugs such as cardiac glycosides, antianginal drugs, and ant ischemic drugs. Anti-hypertensive drugs segment is projected to hold dominant share of global cardiovascular drugs market while anti-hyperlipidemics segment is likely to register steady growth during the forecast period from 2017 to 2025.
Based on the distribution channel, the global cardiovascular drugs market is segmented into retail pharmacies, hospital pharmacies and online pharmacies. High incidences of hospital visits for cardiovascular disease consultation and rise in emergency department visits is likely to contribute for steady growth of hospital pharmacies segment.
Cardiovascular Drugs Market: Geographical and Competitive Dynamics
Geographically, the global cardiovascular drugs market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.
The report also profiles major players in the cardiovascular drugs market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include AstraZeneca plc., Pfizer Inc., Novartis AG, Merck & Co., Inc., Bristol-Myers Squibb Company, Bayer AG, Sanofi, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Gilead Sciences, Inc., Johnson & Johnson, Astellas Pharma, Inc., Eli Lilly and Company, Otsuka Holdings Co., Ltd., Takeda Pharmaceutical Company Limited.
The global cardiovascular drugs market has been segmented as below:
Global Cardiovascular Drugs Market, by Drug Class
Anti hyperlipidemics
Antihypertensive
Anti-coagulants
Antifibrinolytic
Antiarrhythmic
Others ( Cardiac Glycosides, antianginal drugs, anti-ischemic drugs)
Global Cardiovascular Drugs Market, by Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Cardiovascular Drugs Market, by Geography
North America
S.
Canada
Europe
Germany
France
K.
Spain
Italy
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East and Africa
Make An Enquiry @ https://www.mrrse.com/enquiry/3877
About Us
Market Research Reports Search Engine(MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
Contact
State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website : https://www.mrrse.com/
Read More Industry News At: https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Latest Research Analysis on Cardiovascular Drugs Market Will Rise At 1.5%CAGR BY 2025 here
News-ID: 830695 • Views: …
More Releases from Market Research Reports - MRRSE
Global Dairy Market Will Reach Value of US$ 9,570 Mn by 2022
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Dairy Alternatives Market: North America to dominate the market throughout the assessment period: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2022)”.
Click here For Free Sample Report @ https://www.mrrse.com/sample/3558
The dairy alternatives market is growing at a steady pace the…
Civilian Less Lethal and Self Defense Weapons Market Valued at US$82.16 Million …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Civilian Less Lethal and Self Defense Weapons Market - North America Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”…
Click here For Free Sample Report @ https://www.mrrse.com/sample/1764
Less lethal and self-defense weapons also known as “non-lethal” weapons are growing in demand…
Market Research on Biosimulation Market To Worth US$ 1,750 Million in 2022
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Global Market Study on Biosimulation: North America to Dominate the Market in Terms of Revenue During the Forecast Period (2017 - 2022)”...
Request Free Sample Report @ https://www.mrrse.com/sample/3772
Biosimulation is a technique in which computer programs are used for the simulation of biological processes.…
Antiviral Medicine Market Anticipate it to Increase to US$82.9 bn by 2024
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Antiviral Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024” …
Request Free Sample Report @ https://www.mrrse.com/sample/2551
With the significant increase in the incidence of viral infections, the global antiviral medicine market is witnessing a substantial rise in…
More Releases for Cardiovascular
Increasing Prevalence of Cardiovascular Diseases to Augment the Cardiovascular I …
Cardiovascular information system offers on-time access to cardiovascular electronic medical records in reports, images, and waveforms, and allows easy report generation and distribution. Cardiovascular information system is extensively used in electrocardiography (ECG) data management, echocardiography, catheterization, and vascular solutions.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/20
Cardiovascular information system is used to store, archive, and share healthcare information. It is a unique software solution that helps improve the clinical and financial…
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region.
Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,…
Mexico Cardiovascular Devices Market Outlook to 2025 Cardiac Assist Devices, Car …
Orbisresearch.com has announced the addition of Mexico Cardiovascular Devices Market. The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
Mexico Cardiovascular Devices Market Outlook to 2025, provides key market data on the Mexico Cardiovascular Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Cardiac Assist Devices, Cardiac Rhythm…
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven…
Increasing Cardiovascular Surgeries Leads To Higher Market Value For Cardiovascu …
When a coronary artery is narrowed by the accumulation of fatty acids, also known as plaque, the blood flow to heart is reduced which result in the chest pain and if the blockage increases the blood flow to the heart is further reduced and might lead to cardiac arrest. To reduce the chances of heart attack, a tiny wire mesh tube is inserted in the artery with a balloon catheter,…
Cardiovascular Monitoring and Diagnostic Devices Market to be Driven with the Ri …
The global market for cardiovascular monitoring and diagnostic devices is expected to expand at a healthy CAGR of 6.4% over the period between 2016 and 2024, rising from a valuation of US$1.8 bn in 2015 to US$3.1 bn by 2024. The segment of ECG systems contributed the largest share to the market’s overall revenues in 2015, accounting for nearly US$878 mn in 2015. However, the segment of implantable loop recorder…
